Skip To Main Content

Transplantační medicína

Nejnovější trendy

Prozkoumejte nejčtenější články a videa na Campus Sanofi

Seřadit

VENTURE publication

TRAVERSE publication

IL-4-and-IL-13

Module 2: An update on RACGP guidelines - Type 2 Diabetes - Special Populations

Type 2 Inflammation in Asthma

IL-4 and IL-13 are key and central drivers of type 2 inflammation1-3

Module 1: An update on RACGP guidelines - Refreshing Key Concepts of Type 2 Diabetes

The updated RACGP guidelines on the management of type 2 diabetes is an important primary care tool that provides GPs and other health professionals with information and recommendations based on the latest body of evidence.

Type 2 inflammation in CRSwNP

Type 2 Inflammation drives Atopic Dermatitis

Several cytokines, including IL-4, IL-13, and IL-31, contribute to type 2 inflammation and the clinical disease features of atopic dermatitis, including barrier dysfunction, increased susceptibility to skin infection and chronic itch which all drive eczematous skin lesions.3–7*

Understanding Atopic Dermatitis

Atopic dermatitis is a chronic, inflammatory skin disease in which the Th2 cytokines IL-4 and IL-13 are key drivers involved with the underlying inflammatory process.1

SINUS-24 and SINUS-52 publication

Clinical Trial Program in CRSwNP